Metoclopramida Labesfal

Metoclopramide, the active ingredient in Metoclopramida Labesfal, is a dopamine antagonist presented as an injectable solution for intramuscular and intravenous use. It is employed to treat nausea and vomiting, including postoperative and chemotherapy‑induced cases, as well as gastroparesis. GNH USA supplies Metoclopramida Labesfal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide acts on the dopaminergic pathways that trigger nausea and delayed gastric emptying. - Nausea and vomiting: reduces the frequency and severity of acute episodes. - Postoperative nausea and vomiting: lowers incidence after surgical procedures. - Gastroparesis: enhances gastric motility and improves stomach emptying. - Chemotherapy‑induced nausea and vomiting: alleviates symptoms associated with anticancer treatment.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: mild sedation or fatigue. - Restlessness: feeling of inner tension or agitation. - Diarrhea: increased bowel movements. - Extrapyramidal symptoms: muscle stiffness or tremor. - Headache: mild to moderate pain. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Tardive dyskinesia: involuntary, repetitive movements. - Neuroleptic malignant syndrome: high fever, muscle rigidity. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Cardiac arrhythmia: irregular heart rhythm. - Hyperprolactinemia: elevated prolactin causing galactorrhea.

Metoclopramide requires careful consideration of patient history and monitoring. - Contraindication: avoid in patients with known hypersensitivity to the drug. - Caution: use with care in individuals with Parkinson's disease or seizure disorders. - Monitoring: assess for signs of extrapyramidal reactions, especially with prolonged therapy. - Pregnancy: safety not established; weigh potential benefits against risks. - Breastfeeding: unknown excretion; consider alternatives. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Metoclopramide can alter the effects of several concomitant medications.

Major Interactions (Avoid): - Antipsychotics: may increase risk of extrapyramidal symptoms. - MAO inhibitors: can potentiate hypertensive reactions. - CYP2D6 substrates: may affect metabolism of drugs like codeine.

Moderate Interactions (Monitor Closely): - Opioids: enhanced sedation and respiratory depression. - Anticholinergics: may reduce prokinetic efficacy. - SSRIs: potential for additive serotonergic effects.